Race Oncology Limited (ASX: RAC) (Race) is pleased to release an updated
investor presentation and invite investors to join a special online investor briefing.
Investors are invited to attend a special briefing session where Managing Director and CEO, Phillip Lynch and CSO and Executive Director, Dr Daniel Tillett will discuss progress on the Company’s Three Pillar strategy, as well as the recently announced capital raise and Bonus Options Issue. Details as follows:
Thursday 13 May from 10:30am AEST
Investors will be invited to ask questions during the session.